Safety of rush immunotherapy with hymenoptera venom;Seguridad de la inmunoterapia con una pauta rápida con veneno de himenópteros

Allergologia et Immunopathologia

Volumn 33, Issue 4, 2005, Pages 224-227

  Sanchez Morillas L ^a   Reano Martos M ^a   Rodriguez Mosquera M ^a   Iglesias Cadarso, A ^a   Dominguez Lazaro A R ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Hymenoptera; Rush immunotherapy; Safety; Tolerance; Venom

Indexed keywords

ADRENALIN; ALLERGOVAC SOLUBLE; ANTIHISTAMINIC AGENT; DEXCHLORPHENIRAMINE; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; METHYLPREDNISOLONE;

ADULT; ANAMNESIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BEE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNITY; IMMUNOTHERAPY; INCIDENCE; INJECTION SITE; INSECT ALLERGY; MALE; PRICK TEST; SKIN MANIFESTATION; URTICARIA; WASP;

EID: 26944452446     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077748     Document Type: Article

References (21)

1. Müller U, Mosbech H. Immunotherapy with Hymenoptera venoms. Allergy. 1993;48:36-46.
2. Moreno Aguilar C, Guerra Pasadas F. Inmunoterapia con veneno de himenópteros. Seguridad de una pauta agrupada. Alergol Inmunol Clin. 1999;14:315-21.
3. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol. 1998;101:606-12.
4. Westall GP, Thien FC, Czarny D, O'Hehir RE, Douglas JA. Med J Aust. 2001;174(5):227-30.
5. Sturm G, Kranke B, Rudolph C, Aberer W. Rush hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol. 2002;110:928-33.
6. Golden DBK, Valentine MD, Kagay-Sobolka A, Lichtenstein LM. Regimens of hymenoptera venom immunotherapy. Ann Intern Med. 1980;92:620-4.
7. Nataf P, Guinnepain MT, Herman D. Rush-venom immunotherapy: a 3-day programme for hymenoptera sting allergy. Clin Allergy. 1984;14:269-75.
8. Van der Zwan JC, Flinterrman J, Jankowski IJ, Kerckhaert JA. Hyposensitization to wasp venom in six hours. Br Med J. 1983;287:1329-31.
9. Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with hymenoptera anaphylaxis. Ann Allergy. 1994;73:428-8.
10. Birnbaum J, Charpin D, Verloet D. Rapid hymenoptera venom immunotherapy. Comparative safety of three protocols. Clin Exp Allergy. 1993;23:226-30.
11. Reisman RE, Livingston A. 10 years of experience with administration of single venoms and 50 micrograms maintenance doses. J Allergy Clin Immunol. 1992;89:1189-95.
12. Laurent J, Smiejan JM, Bloch-Morot E, Herman D. Safety of hymenoptera venom rush immunotherapy. Allergy. 1997;52:94-6.
13. Golden DBK, Schwartz HJ. Guidelines for venom immunotherapy. J Allergy Clin Immunol. 1985;77:727-8.
14. Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, Bukantz SC. The hymenoptera venom study. Safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86:775-80.
15. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med. 1991;23:1601-3.
16. Bousquet J, Müller UR, Dreborg S et al. Immunotherapy with hymenoptera venoms. Allergy. 1987;42:401-13.
17. Chabane MH, Leynadier F, Halpern GM, Dry J. Serum sickness with acquired precipitating antibodies during rush immunotherapy (2 cases). Ann Allergy. 1988;61:216.
18. Diez Gómez ML, Quirce Gancedo S, Páramo J. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy. Allergol et Immunopathol. 1995;23:277-84.
19. Brehler R, Wolf H, Kütting B, Schnitker J, Luger T. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol. 2000;105:1231-4.
20. Engler RJ, Davis WS. Rush hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease. J Allergy Clin Immunol. 1994;94:556-9.
21. Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment. J Allergy Clin Immunol. 2002;109:556-62.